INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 123 filers reported holding INTERSECT ENT INC in Q1 2020. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $257,000 | -35.8% | 15,024 | -21.5% | 0.00% | -50.0% |
Q1 2021 | $400,000 | -34.6% | 19,136 | -49.0% | 0.00% | -75.0% |
Q3 2020 | $612,000 | -48.9% | 37,550 | -21.9% | 0.01% | +14.3% |
Q4 2019 | $1,197,000 | +51.9% | 48,061 | +38.7% | 0.01% | -12.5% |
Q2 2019 | $788,000 | -30.0% | 34,639 | -1.0% | 0.01% | -33.3% |
Q1 2019 | $1,125,000 | -14.3% | 34,987 | -24.9% | 0.01% | -20.0% |
Q4 2018 | $1,313,000 | -0.8% | 46,588 | +1.2% | 0.02% | -6.2% |
Q3 2018 | $1,324,000 | -10.5% | 46,041 | +16.6% | 0.02% | -20.0% |
Q2 2018 | $1,479,000 | +33.8% | 39,500 | +40.5% | 0.02% | +11.1% |
Q1 2018 | $1,105,000 | +26.9% | 28,113 | +4.6% | 0.02% | +20.0% |
Q4 2017 | $871,000 | +58.1% | 26,880 | +52.1% | 0.02% | +36.4% |
Q3 2017 | $551,000 | +126.7% | 17,676 | +103.2% | 0.01% | +120.0% |
Q2 2017 | $243,000 | -37.9% | 8,700 | -73.1% | 0.01% | -68.8% |
Q4 2016 | $391,000 | +7.1% | 32,313 | +99.5% | 0.02% | -60.0% |
Q4 2015 | $365,000 | – | 16,200 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |